Exhibit 99.2
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
Introduction
On November 1, 2024 (the Closing Date), Kewaunee Scientific Corporation (Kewaunee, or the Company) completed an acquisition (the Acquisition) of Nu Aire, Inc. (Nu Aire) pursuant to the terms of the Securities Purchase Agreement (the Purchase Agreement), dated as of the Closing Date, by and among the Company, Nu Aire, Richard A. Peters, William F. Peters, Rita Peters Revocable Trust, and any amendments thereto (Rita Trust), Richard A. Peters Irrevocable Trust dated May 18, 2020, and any amendments thereto (R. Peters 2020 Trust), Richard A. Peters Revocable Trust, and any amendments thereto (R. Peters 2005 Trust), Karan A. Peters Revocable Trust, and any amendments thereto (K. Peters Trust), William F. Peters 2023 Irrevocable Trust dated December 20, 2023, and any amendments thereto (W. Peters 2023 Trust), William F. Peters Revocable Trust, and any amendments thereto (W. Peters Trust and, together with Richard A. Peters, William F. Peters, Rita Trust, R. Peters 2020 Trust, R. Peters 2005 Trust, K. Peters Trust, and W. Peters 2023 Trust, the Sellers and each, a Seller) and William F Peters as Sellers Representative.
The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X.
The unaudited pro forma condensed combined balance sheet as of October 31, 2024 gives effect to the Acquisition and the debt financing (see Description of the Financing for explanation of the debt financing) as if those transactions had been completed on October 31, 2024. The unaudited pro forma condensed combined statements of operations for the year ended April 30, 2024 and the six months ended October 31, 2024 give effect to the Acquisition and the debt financing as if those transactions had occurred on May 1, 2023, the first day of Kewaunees fiscal year 2024 and combines the historical results of Kewaunee and Nu Aire.
The historical financial statements of Kewaunee and Nu Aire have been adjusted in the accompanying unaudited pro forma condensed combined financial information to give effect to pro forma events that are transaction accounting adjustments which are necessary to account for the Acquisition and the debt financing, in accordance with U.S. GAAP. The unaudited pro forma adjustments are based upon available information and certain assumptions that our management believes are reasonable.
The unaudited pro forma condensed combined financial information should be read in conjunction with:
| | The accompanying notes to the unaudited pro forma condensed combined financial information; |
| | The separate audited financial statements of Kewaunee as of and for the fiscal year ended April 30, 2024 and the related notes, included in Kewaunees Annual Report on Form 10-K for the fiscal year ended April 30, 2024; |
| | The separate unaudited financial statements of Kewaunee as of and for the six months ended October 31, 2024 and the related notes, included in Kewaunees Quarterly Report on Form 10-Q for the period ended October 31, 2024; and |
| | The separate audited financial statements of Nu Aire as of and for the fiscal year ended September 30, 2024 and the related notes, included as an exhibit to this Form 8-K/A. |
Description of the Financing
Kewaunee purchased all of the outstanding capital stock of Nu Aire from the Sellers for $55 million in the aggregate (the Purchase Price), subject to adjustments for debt, cash, transaction expenses and net working capital, as further described in the Purchase Agreement (the Transaction). The Company funded the Purchase Price with a combination of proceeds from a Loan Agreement (as defined below) with PNC Bank, National Association (PNC) and subordinated notes issued to the Sellers in conjunction with the closing of the Acquisition (the Seller Notes). The Loan Agreement and the Seller Notes are collectively referred to herein as the debt financing or financing.
Loan Agreement
On the Closing Date, Kewaunee entered into a Loan Agreement with PNC. The loans governed by the Loan Agreement include:
| | a $20 million committed senior secured revolving line of credit facility (the Revolving Credit Facility), which contains an option to increase the facility by an additional $10 million upon request by Kewaunee and approval by PNC, in its discretion; and |
| | a $15 million term loan (the Term Loan). |
The Revolving Credit Facility and Term Loan mature on the 5-year anniversary of the Closing, or November 1, 2029.
For the Revolving Credit Facility, the interest rate will be selected by Kewaunee at each advance from one of two options. Option one will be a base rate option which will be the highest of the following: (1) PNC prime rate, (2) an overnight bank funding rate as determined by the Federal Reserve Bank of New York plus 50 basis points, or (3) the sum of the daily simple secured overnight financing rate administered by the Federal Reserve Bank of New York, as adjusted by PNC, plus 100 basis points, plus 10 basis points in each case increased by an Applicable Margin of 50 to 100 basis points determined by the ratio of senior debt to Kewaunees EBITDA. Option two will be a daily secured overnight financing rate plus 150 to 200 basis points determined by the ratio of senior debt to Kewaunees EBITDA and plus 10 basis points. There is an unused fee of 0.15% to 0.25%, determined by the ratio of senior debt to Kewaunees EBITDA, of the unused daily balance of the Revolving Credit Facility. This unused fee is calculated on the basis of a 360-day year for the actual number of days elapsed and paid quarterly.
For the Term Loan, the principal will be paid in 60 substantially equal monthly installments commencing on the Closing Date. Interest will be paid at the same time and calculated on the outstanding principal balance at an interest rate equal to the rate under Option two of the Revolving Credit Facility.
Seller Notes
As noted above, $23 million of the Purchase Price was paid by the issuance of the Seller Notes entered into by and between Kewaunee and each Seller on the Closing Date. The Seller Notes will accrue interest at 8% per annum and will mature on the third anniversary of the Closing, at which time the outstanding principal amount and all unpaid accrued interest will become due and payable by the Company.
The rights of the Sellers to receive payments under the Seller Notes are subordinate to the rights of PNC under the Loan Agreement pursuant to the separate Subordination Agreements that the Sellers entered into with PNC on the Closing Date in connection with the Transaction.
Accounting for the Acquisition
The Acquisition is being accounted for as a business combination using the acquisition method with Kewaunee as the accounting acquirer in accordance with Accounting Standards Codification (ASC) Topic 805, Business Combinations. Under this method of accounting, the aggregate consideration will be allocated to Nu Aires assets acquired and liabilities assumed based upon their estimated fair values at the date of completion of the Acquisition. The process of valuing the net assets of Nu Aire immediately prior to the Acquisition, as well as evaluating accounting policies for conformity, is preliminary. Any differences between the estimated fair value of the consideration transferred and the estimated fair value of the assets acquired and liabilities assumed will be recorded as goodwill. Accordingly, the aggregate acquisition consideration allocation and related adjustments reflected in this unaudited pro forma condensed combined financial information are preliminary and subject to revision based on a final determination of fair value. Refer to Note 1 Basis of Presentation for more information.
All financial data included in the unaudited condensed combined financial information is presented in thousands of U.S. Dollars and shares, except per share amounts, and has been prepared on the basis of U.S. GAAP and Kewaunees accounting policies.
The unaudited pro forma condensed combined financial information presented is for informational purposes only and is not necessarily indicative of the financial position or results of operations that would have been realized if the Acquisition and the debt financing had been completed on the dates set forth above, nor is it indicative of the future results or financial position of the combined company.
UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET
As of October 31, 2024
($ in thousands)
| Kewaunee Scientific Corporation Historical As of October 31, 2024 |
Nu Aire, Inc. Reclassed As of October 31, 2024 (Note 2) |
Transaction Accounting Adjustments |
(Note 4) | Transaction Accounting Adjustments Financing |
(Note 4) | Pro Forma Combined |
||||||||||||||||||||||
| Assets |
||||||||||||||||||||||||||||
| Current Assets: |
||||||||||||||||||||||||||||
| Cash and cash equivalents |
$ | 25,963 | $ | 1,245 | $ | (29,055 | ) | (a) | $ | 20,050 | (a) | $ | 18,203 | |||||||||||||||
| Restricted cash |
3,701 | | | | 3,701 | |||||||||||||||||||||||
| Receivables, less allowance |
41,885 | 10,650 | | | 52,535 | |||||||||||||||||||||||
| Inventories |
18,659 | 13,108 | 636 | (b) | | 32,403 | ||||||||||||||||||||||
| Prepaid expenses and other current assets |
6,228 | 827 | | | 7,055 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total Current Assets |
$ | 96,436 | $ | 25,830 | $ | (28,419 | ) | $ | 20,050 | $ | 113,897 | |||||||||||||||||
| Net Property, Plant and Equipment |
16,990 | 2,514 | 4,581 | (c) | | 24,085 | ||||||||||||||||||||||
| Goodwill |
| | (9,971 | ) | (d) | 23,000 | (d) | 13,029 | ||||||||||||||||||||
| Other intangible assets, net |
| | 18,600 | (e) | | 18,600 | ||||||||||||||||||||||
| Right of use assets |
6,941 | 6,320 | 1,244 | (f) | | 14,505 | ||||||||||||||||||||||
| Deferred income taxes |
8,305 | 618 | (5,263 | ) | (g) | | 3,660 | |||||||||||||||||||||
| Other assets |
5,806 | 7 | | 53 | (h) | 5,866 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total Assets |
$ | 134,478 | $ | 35,289 | $ | (19,228 | ) | $ | 43,103 | $ | 193,642 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Liabilities and Stockholders Equity |
||||||||||||||||||||||||||||
| Current Liabilities: |
||||||||||||||||||||||||||||
| Short-term borrowings |
$ | 805 | $ | | $ | | $ | | $ | 805 | ||||||||||||||||||
| Current portion of financing liability |
750 | | | 3,000 | (h) | 3,750 | ||||||||||||||||||||||
| Current portion of financing lease liabilities |
109 | | | | 109 | |||||||||||||||||||||||
| Current portion of operating lease liabilities |
2,112 | 1,311 | | | 3,423 | |||||||||||||||||||||||
| Accounts payable |
21,458 | 4,293 | | | 25,751 | |||||||||||||||||||||||
| Employee compensation and amounts withheld |
3,708 | 2,642 | | | 6,350 | |||||||||||||||||||||||
| Deferred revenue |
6,239 | 636 | | | 6,875 | |||||||||||||||||||||||
| Other accrued expenses |
1,290 | 1,890 | 698 | (i) | | 3,878 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total Current Liabilities |
$ | 36,471 | $ | 10,772 | $ | 698 | $ | 3,000 | $ | 50,941 | ||||||||||||||||||
| Long-term portion of financing liability |
27,032 | | | 40,103 | (h) | 67,135 | ||||||||||||||||||||||
| Long-term portion of financing lease liabilities |
156 | | | | 156 | |||||||||||||||||||||||
| Long-term portion of operating lease liabilities |
5,035 | 5,289 | | | 10,324 | |||||||||||||||||||||||
| Accrued pension and deferred compensation costs |
3,625 | | | | 3,625 | |||||||||||||||||||||||
| Deferred income taxes |
1,042 | | | | 1,042 | |||||||||||||||||||||||
| Other non-current liabilities |
460 | | | | 460 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total Liabilities |
$ | 73,821 | $ | 16,061 | $ | 698 | $ | 43,103 | $ | 133,683 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Commitments and Contingencies |
||||||||||||||||||||||||||||
| Stockholders Equity: |
||||||||||||||||||||||||||||
| Common stock |
7,353 | 30 | (30 | ) | (j) | | 7,353 | |||||||||||||||||||||
| Additional paid-in-capital |
4,885 | 12 | (12 | ) | (j) | | 4,885 | |||||||||||||||||||||
| Retained earnings |
52,715 | 19,186 | (19,884 | ) | (j) | | 52,017 | |||||||||||||||||||||
| Accumulated other comprehensive loss |
(3,574 | ) | | | | (3,574 | ) | |||||||||||||||||||||
| Common stock in treasury, at cost |
(2,051 | ) | | | | (2,051 | ) | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total Kewaunee Scientific Corporation Stockholders Equity |
$ | 59,328 | $ | 19,228 | $ | (19,926 | ) | $ | | $ | 58,630 | |||||||||||||||||
| Non-controlling interest |
1,329 | | | | 1,329 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total Stockholders Equity |
60,657 | 19,228 | (19,926 | ) | | 59,959 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total Liabilities and Stockholders Equity |
$ | 134,478 | $ | 35,289 | $ | (19,228 | ) | $ | 43,103 | $ | 193,642 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
See the accompanying notes to the Unaudited Pro Forma Condensed Combined Financial Information
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
For The Six Months Ended October 31, 2024
($ and shares in thousands, except per share amounts)
| Kewaunee Scientific Corporation Historical Six Months Ended October 31, 2024 |
Nu Aire, Inc. Reclassed Six Months Ended October 31, 2024 (Note 2) |
Transaction Accounting Adjustments |
(Note 5) | Transaction Accounting Adjustments Financing |
(Note 5) | Pro Forma Combined |
(Note 5) | |||||||||||||||||||||||||
| Net sales |
$ | 96,157 | $ | 36,224 | $ | | $ | | $ | 132,381 | ||||||||||||||||||||||
| Cost of products sold |
69,717 | 25,885 | 9 | (a) | | 95,611 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Gross profit |
26,440 | 10,339 | (9 | ) | | 36,770 | ||||||||||||||||||||||||||
| Operating expenses |
19,431 | 9,125 | 905 | (b) | 5 | (c) | 29,466 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Operating profit |
7,009 | 1,214 | (914 | ) | (5 | ) | 7,304 | |||||||||||||||||||||||||
| Other income, net |
266 | 572 | | | 838 | |||||||||||||||||||||||||||
| Interest expense |
(914 | ) | | | (1,734 | ) | (c) | (2,648 | ) | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Profit before income taxes |
6,361 | 1,786 | (914 | ) | (1,739 | ) | 5,494 | |||||||||||||||||||||||||
| Income tax (benefit) expense |
1,108 | 18 | (192 | ) | (d) | (365 | ) | (d) | 569 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Net earnings |
5,253 | 1,768 | (722 | ) | (1,374 | ) | 4,925 | |||||||||||||||||||||||||
| Less: Net earnings attributable to the non-controlling interest |
52 | | | | 52 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Net earnings attributable to Kewaunee Scientific Corporation |
$ | 5,201 | $ | 1,768 | $ | (722 | ) | $ | (1,374 | ) | $ | 4,873 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Net earnings per share attributable to Kewaunee Scientific Corporation stockholders |
||||||||||||||||||||||||||||||||
| Basic |
$ | 1.82 | $ | 1.70 | (e) | |||||||||||||||||||||||||||
| Diluted |
$ | 1.75 | $ | 1.64 | (e) | |||||||||||||||||||||||||||
| Weighted average number of common shares outstanding |
||||||||||||||||||||||||||||||||
| Basic |
2,861 | 2,861 | ||||||||||||||||||||||||||||||
| Diluted |
2,971 | 2,971 | ||||||||||||||||||||||||||||||
See the accompanying notes to the Unaudited Pro Forma Condensed Combined Financial Information.
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
For the Year Ended April 30, 2024
($ and shares in thousands, except per share amounts)
| Kewaunee Scientific Corporation Historical Year Ended April 30, 2024 |
Nu Aire, Inc. Reclassed Year Ended April 30, 2024 (Note 2) |
Transaction Accounting Adjustments |
(Note 5) | Transaction Accounting Adjustments Financing |
(Note 5) | Pro Forma Combined |
(Note 5) | |||||||||||||||||||||||||
| Net sales |
$ | 203,755 | $ | 80,875 | $ | | $ | | $ | 284,630 | ||||||||||||||||||||||
| Cost of products sold |
151,704 | 55,054 | 638 | (a) | | 207,396 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Gross profit |
52,051 | 25,821 | (638 | ) | | 77,234 | ||||||||||||||||||||||||||
| Operating expenses |
33,770 | 20,169 | 2,467 | (b) | 11 | (c) | 56,417 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Operating profit |
18,281 | 5,652 | (3,105 | ) | (11 | ) | 20,817 | |||||||||||||||||||||||||
| Pension expense |
(4,177 | ) | | | | (4,177 | ) | |||||||||||||||||||||||||
| Other income, net |
814 | 418 | | | 1,232 | |||||||||||||||||||||||||||
| Interest expense |
(1,799 | ) | | | (3,479 | ) | (c) | (5,278 | ) | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Profit before income taxes |
13,119 | 6,070 | (3,105 | ) | (3,490 | ) | 12,594 | |||||||||||||||||||||||||
| Income tax (benefit) expense |
(5,938 | ) | 1,034 | (652 | ) | (d) | (733 | ) | (d) | (6,289 | ) | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Net earnings |
19,057 | 5,036 | (2,453 | ) | (2,757 | ) | 18,883 | |||||||||||||||||||||||||
| Less: Net earnings attributable to the non-controlling interest |
304 | | | | 304 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Net earnings attributable to Kewaunee Scientific Corporation |
$ | 18,753 | $ | 5,036 | $ | (2,453 | ) | $ | (2,757 | ) | $ | 18,579 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
| Net earnings per share attributable to Kewaunee Scientific Corporation stockholders |
||||||||||||||||||||||||||||||||
| Basic |
$ | 6.51 | $ | 6.45 | (e) | |||||||||||||||||||||||||||
| Diluted |
$ | 6.38 | $ | 6.32 | (e) | |||||||||||||||||||||||||||
| Weighted average number of common shares outstanding |
||||||||||||||||||||||||||||||||
| Basic |
2,879 | 2,879 | ||||||||||||||||||||||||||||||
| Diluted |
2,938 | 2,938 | ||||||||||||||||||||||||||||||
See the accompanying notes to the Unaudited Pro Forma Condensed Combined Financial Information.
NOTES TO THE UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
Note 1 - Basis of Presentation
The unaudited pro forma condensed combined financial information and related notes are prepared in accordance with Article 11 of Regulation S-X as amended by the final rule, Release No. 33-10786 Amendments to Financial Disclosures about Acquired and Disposed Businesses.
Kewaunee and Nu Aires historical financial statements were prepared in accordance with U.S. GAAP and presented in U.S. dollars. As discussed in Note 2, certain reclassifications were made to align Kewaunee and Nu Aires financial statement presentation. Kewaunee is currently in the process of evaluating Nu Aires accounting policies and as a result of that review, additional differences could be identified between the accounting policies of the two companies. With the information currently available, Kewaunee has determined that no significant adjustments are necessary to conform Nu Aires financial statements to the accounting policies used by Kewaunee.
The unaudited pro forma condensed combined financial information was prepared using the acquisition method of accounting in accordance with ASC 805, with Kewaunee as the accounting acquirer, using the fair value concepts defined in ASC Topic 820, Fair Value Measurement, and based on the historical financial statements of Kewaunee and Nu Aire. Under ASC 805, all assets acquired and liabilities assumed in a business combination are recognized and measured at their assumed acquisition date fair value, while transaction costs associated with the business combination are expensed as incurred. The excess of consideration over the estimated fair value of assets acquired and liabilities assumed, if any, is allocated to goodwill.
The allocation of the aggregate consideration depends upon certain estimates and assumptions, all of which are preliminary. The allocation of the aggregate consideration has been made for the purpose of developing the unaudited pro forma condensed combined financial information. The allocation of the aggregate consideration set forth herein is preliminary and will be revised as additional information becomes available during the measurement period, which could be up to twelve months from the Closing Date. Any such revisions or changes may be material.
Pursuant to Rule 11-02(c)(3) of Regulation S-X, if the fiscal year end of an acquired entity differs from the acquirers fiscal year end by more than 93 days, the acquired entitys statement of operations must be brought up within 93 days of the acquirers fiscal year end.
The unaudited pro forma condensed combined balance sheet, as of October 31, 2024, the unaudited pro forma condensed combined statement of operations for the six months ended October 31, 2024 and the unaudited pro forma condensed combined statement of operations for the year ended April 30, 2024, presented herein, are based on the historical financial statements of Kewaunee and Nu Aire. As a result of Kewaunee having a different fiscal period-end than Nu Aire, the unaudited pro forma condensed combined financial information has been aligned as follows:
The unaudited pro forma condensed combined balance sheet as of October 31, 2024 is presented as if the Acquisition and debt financing had occurred on October 31, 2024 and combines the historical balance sheet of Kewaunee as of October 31, 2024 with the unaudited accounting records of Nu Aire as of October 31, 2024.
| | The unaudited pro forma condensed combined statement of operations for the six months ended October 31, 2024 has been prepared as if the Acquisition and debt financing had occurred on May 1, 2023 and combines Kewaunees historical statement of operations for the six months ended October 31, 2024 with Nu Aires historical statement of operations for the six months ended October 31, 2024. |
| | Nu Aires historical statement of operations for the six months ended October 31, 2024 was derived from the historical statement of operations for the twelve months ended September 30, 2024 and Nu Aires internal accounting records. |
| | The unaudited pro forma condensed combined statement of operations for the year ended April 30, 2024 has been prepared as if the Acquisition and debt financing had occurred on May 1, 2023 and combines Kewaunees historical statement of operations for the fiscal year ended April 30, 2024 with Nu Aires historical statement of operations for the 12 months ended April 30, 2024. |
| | Nu Aires historical statement of operations for the 12 months ended April 30, 2024 was derived from the historical statement of operations for the twelve months ended September 30, 2023 and September 30, 2024 and Nu Aires internal accounting records. |
The unaudited pro forma condensed combined financial information does not reflect any anticipated synergies or dissynergies, operating efficiencies or cost savings that may result from the Acquisition or any integration costs that may be incurred. The pro forma adjustments represent managements best estimates and are based upon currently available information and certain assumptions that Kewaunee believes are reasonable under the circumstances. Kewaunee is not aware of any material transactions between Kewaunee and Nu Aire during the periods presented. Accordingly, adjustments to eliminate transactions between Kewaunee and Nu Aire have not been reflected in the unaudited pro forma condensed combined financial information.
Note 2 - Nu Aire reclassification adjustments
During the preparation of this unaudited pro forma condensed combined financial information, management performed a preliminary analysis of Nu Aires financial information to identify differences in financial statement presentation as compared to the financial statement presentation of Kewaunee. Certain reclassification adjustments have been made to conform Nu Aires historical financial statement presentation to Kewaunees financial statement presentation. Kewaunee is currently in the process of conducting a more detailed review of reclassifications, which could be materially different from the amounts set forth in the unaudited pro forma condensed combined financial information presented herein.
| A) | Refer to the table below for a summary of reclassification adjustments made to Nu Aires balance sheet as of October 31, 2024 in order to conform the presentation with that of Kewaunee: |
| ($ in thousands) | ||||||||||||||||||
| Nu Aire, Inc. Historical Condensed Consolidated Balance Sheet Line Items |
Kewaunee Scientific Corporation Historical Condensed Consolidated Balance Sheet Line Items |
Nu Aire, Inc. Historical Condensed Consolidated Balances As of October 31, 2024 |
Reclassification | Notes | Nu Aire, Inc. Reclassed As of October 31, 2024 |
|||||||||||||
| Cash and Cash Equivalents |
Cash and cash equivalents | $ | 1,245 | $ | | $ | 1,245 | |||||||||||
| Accounts Receivable, Net of Allowance for Credit Losses |
Receivables, less allowance | 10,650 | | 10,650 | ||||||||||||||
| Inventories, Net |
Inventories | 13,108 | | 13,108 | ||||||||||||||
| Prepaid Expenses |
Prepaid expenses and other current assets | 672 | 155 | (a) | 827 | |||||||||||||
| Income Taxes Receivable |
155 | (155 | ) | (a) | | |||||||||||||
| Total Property and Equipment (at Depreciated Cost) |
Net Property, Plant and Equipment | 2,514 | | 2,514 | ||||||||||||||
| Operating Right-of-Use Asset, Net |
Right of use assets | 6,320 | | 6,320 | ||||||||||||||
| Deferred Tax Asset |
Deferred income taxes | 618 | | 618 | ||||||||||||||
| Deposits |
Other assets | 7 | | 7 | ||||||||||||||
| Current Portion of Lease Liability - Operating |
Current portion of operating lease liabilities | 1,311 | | 1,311 | ||||||||||||||
| Accounts Payable |
Accounts payable | 4,370 | (77 | ) | (b) | 4,293 | ||||||||||||
| Accrued Compensation |
Employee compensation and amounts withheld | 1,828 | 814 | (b), (c), (d) | 2,642 | |||||||||||||
| Accrued Commissions |
916 | (916 | ) | (c) | | |||||||||||||
| Deferred revenue | | 636 | (c) | 636 | ||||||||||||||
| Other Accrued Expenses |
Other accrued expenses | 2,239 | (349 | ) | (d), (e), (f) | 1,890 | ||||||||||||
| Income Taxes Payable |
108 | (108 | ) | (f) | | |||||||||||||
| Long-Term Lease Liability - Operating (Less Current Portion) |
Long-term portion of operating lease liabilities | 5,289 | | 5,289 | ||||||||||||||
| Common Stock |
Common stock | 30 | | 30 | ||||||||||||||
| Additional Paid-In Capital |
Additional paid-in-capital | 12 | | 12 | ||||||||||||||
| Retained Earnings |
Retained earnings | 19,186 | | 19,186 | ||||||||||||||
| a) | Reclassification of $0.2 million of Income Taxes Receivable to Prepaid expenses and other current assets. |
| b) | Reclassification of $0.1 million of Accounts Payable to Employee compensation and amounts withheld. |
| c) | Reclassification of $0.9 million of Accrued Commissions to Employee compensation and amounts withheld. |
| d) | Reclassification of $0.2 million of Accrued Compensation to Other accrued expenses. |
| e) | Reclassification of $0.6 million of Other Accrued Expenses to Deferred revenue. |
| f) | Reclassification of $0.1 million of Income Taxes Payable to Other accrued expenses. |
| B) | Refer to the table below for a summary of adjustments made to present Nu Aires statement of operations for the six months ended October 31, 2024 to conform with that of Kewaunees: |
($ in thousands)
| Nu Aire, Inc. Historical Condensed |
Kewaunee Scientific Corporation |
Nu Aire, Inc. Six Months Ended October 31, 2024 |
Reclassification | Notes | Nu Aire, Inc. Reclassed Six Months Ended October 31, 2024 |
|||||||||||||
| Net Revenues |
Net sales | $ | 36,224 | $ | | $ | 36,224 | |||||||||||
| Cost of Revenues |
Cost of products sold | 25,885 | | 25,885 | ||||||||||||||
| Total Operating Expense |
Operating expenses | 9,125 | | 9,125 | ||||||||||||||
| Other Income |
Other income, net | 234 | 338 | (a) | 572 | |||||||||||||
| Interest Income - Net |
338 | (338 | ) | (a) | | |||||||||||||
| Provision for Income Taxes |
Income tax (benefit) expense | 18 | | 18 | ||||||||||||||
| a) | Reclassification of $0.3 million of Interest Income - Net to Other income, net. |
| C) | Refer to the table below for a summary of adjustments made to present Nu Aires statement of operations for the year ended April 30, 2024 to conform with that of Kewaunees: |
($ in thousands)
| Nu Aire, Inc. Historical Condensed |
Kewaunee Scientific Corporation |
Nu Aire, Inc. Year Ended April 30, 2024 |
Reclassification | Notes | Nu Aire, Inc. Reclassed Year Ended April 30, 2024 |
|||||||||||||
| Net Revenues |
Net sales | $ | 80,875 | $ | | $ | 80,875 | |||||||||||
| Cost of Revenues |
Cost of products sold | 55,054 | | 55,054 | ||||||||||||||
| Total Operating Expense |
Operating expenses | 20,169 | | 20,169 | ||||||||||||||
| Other Income |
Other income, net | 95 | 323 | (a) | 418 | |||||||||||||
| Interest Income - Net |
323 | (323 | ) | (a) | | |||||||||||||
| Provision for Income Taxes |
Income tax (benefit) expense | 1,034 | | 1,034 | ||||||||||||||
| a) | Reclassification of $0.3 million of Interest Income - Net to Other income, net. |
Note 3 Preliminary purchase price allocation
Preliminary Aggregate Acquisition Consideration
The following table summarizes the preliminary aggregate acquisition consideration for Nu Aire:
| ($ in thousands) | Amount | |||
| Cash paid to Nu Aire |
$ | 27,744 | ||
| Subordinated Promissory Notes due to Nu Aire |
23,000 | |||
| Payment of Nu Aire transaction expenses |
311 | |||
| Cash paid to escrow |
1,000 | |||
|
|
|
|||
| Preliminary aggregate acquisition consideration (Purchase Price) |
$ | 52,055 | ||
Preliminary Aggregate Acquisition Consideration Allocation
The assumed accounting for the Acquisition, including the preliminary aggregate acquisition consideration, is based on provisional amounts, and the associated purchase accounting is not final. The preliminary allocation of the purchase price to the acquired assets and assumed liabilities was based upon the preliminary estimate of fair values. For the preliminary estimate of fair values of assets acquired and liabilities assumed of Nu Aire, Kewaunee used publicly available benchmarking information as well as a variety of other assumptions, including market participant assumptions. Kewaunee is expected to use widely accepted income-based, market-based, and cost-based valuation approaches upon finalization of purchase accounting for the Acquisition. Actual results may differ materially from the assumptions within the accompanying unaudited pro forma condensed combined financial information. The unaudited pro forma adjustments are based upon available information and certain assumptions that Kewaunee believes are reasonable under the circumstances. The purchase price allocation set forth herein is preliminary and will be revised as additional information becomes available during the measurement period, which could be up to twelve months from the Closing Date. Any such revisions or changes may be material.
The following table summarizes the preliminary aggregate acquisition consideration allocation, as if the Acquisition had been completed on October 31, 2024:
| ($ in thousands) |
Amount | |||
| Assets: |
||||
| Cash and cash equivalents |
$ | 1,245 | ||
| Receivables, less allowance |
10,650 | |||
| Inventories (i) |
13,744 | |||
| Prepaid expenses and other current assets |
827 | |||
| Net Property, Plant and Equipment (ii) |
7,095 | |||
| Goodwill |
13,029 | |||
| Intangibles, net (iii) |
18,600 | |||
| Right of use assets |
7,564 | |||
| Deferred income taxes(iv) |
(4,645 | ) | ||
| Other assets |
7 | |||
| Liabilities: |
||||
| Current portion of operating lease liabilities |
(1,311 | ) | ||
| Accounts payable |
(4,293 | ) | ||
| Employee compensation and amounts withheld |
(2,642 | ) | ||
| Deferred revenue |
(636 | ) | ||
| Other accrued expenses |
(1,890 | ) | ||
| Long-term portion of operating lease liabilities |
(5,289 | ) | ||
|
|
|
|||
| Preliminary aggregate acquisition consideration (Purchase Price) |
$ | 52,055 | ||
|
|
|
|||
| i) | The unaudited pro forma condensed combined balance sheet has been adjusted to record Nu Aires inventories at a preliminary fair value of approximately $13.7 million, an increase of $0.6 million from the carrying value. The unaudited pro forma condensed combined statement of operations for the year ended April 30, 2024 has been adjusted to recognize additional cost of products sold related to the increased basis. The additional costs are not anticipated to affect the condensed combined statement of operations beyond twelve months after the acquisition date. |
| ii) | The unaudited pro forma condensed combined balance sheet has been adjusted to record Nu Aires property, plant and equipment at a preliminary fair value of approximately $7.1 million, an increase of $4.6 million from the carrying value. The unaudited pro forma condensed combined statement of operations have been adjusted to recognize additional depreciation expense related to the increased basis under cost of products sold and operating expenses. Refer to Notes 5(a) and 5(b) below for additional information on the incremental depreciation expense recorded in each period. |
| iii) | Preliminary identifiable intangible assets in the unaudited pro forma condensed combined financial information consists of the following: |
| ($ in thousands) |
Preliminary Fair Value |
Estimated Useful Life | ||||||
| Preliminary fair value of intangible assets acquired: |
||||||||
| Customer relationships |
$ | 9,800 | 10 | |||||
| Trade names and trademarks |
4,900 | | ||||||
| Developed technology |
3,900 | 7 | ||||||
|
|
|
|||||||
| Intangible assets acquired |
$ | 18,600 | ||||||
|
|
|
|||||||
A 10% change in the valuation of intangible assets would cause a corresponding increase or decrease in the amortization expense of approximately $76,857 for the six months ended October 31, 2024 and $153,714 for the year ended April 30, 2024. Pro forma amortization is preliminary and based on the use of straight-line amortization. The amount of amortization following the Acquisition may differ significantly between periods based upon the final value assigned and amortization methodology used for each identifiable intangible asset.
| iv) | The adjustment to deferred tax assets was derived based on incremental differences in the book and tax basis created from the preliminary purchase allocation. |
Note 4 Adjustments to the Unaudited Pro Forma Condensed Combined Balance Sheet
Adjustments included in the Transaction Accounting Adjustments column and Transaction Accounting Adjustments Financing column in the accompanying unaudited pro forma condensed combined balance sheet as of October 31, 2024 are as follows:
| (a) | Reflects adjustment to cash and cash equivalents: |
| ($ in thousands) |
Amount | |||
| Pro forma transaction accounting adjustments: |
||||
| Cash consideration paid to Nu Aire |
$ | (27,744 | ) | |
| Cash payment of Nu Aire transaction expenses |
(311 | ) | ||
| Cash payment to escrow |
(1,000 | ) | ||
|
|
|
|||
| Net pro forma transaction accounting adjustments to cash and cash equivalents |
$ | (29,055 | ) | |
| Pro forma transaction accounting adjustments - financing: |
||||
| Cash from new debt financing, net of debt issuance costs |
$ | 20,050 | ||
| (b) | Reflects the preliminary purchase accounting adjustment for inventories, net based on the acquisition method of accounting. |
| ($ in thousands) |
Amount | |||
| Pro forma transaction accounting adjustments: |
||||
| Elimination of Nu Aires inventories, net |
$ | (13,108 | ) | |
| Preliminary fair value of acquired inventories, net |
13,744 | |||
|
|
|
|||
| Net pro forma transaction accounting adjustment to inventories, net |
$ | 636 | ||
|
|
|
|||
Represents the adjustment of acquired inventories, net to its preliminary estimated fair value. The step up in inventories, net to fair value will increase cost of products sold as the inventories are sold, which for purposes of these pro forma financial statements is assumed to occur within the first year after the Acquisition.
| (c) | Reflects the preliminary purchase accounting adjustment for property, plant and equipment based on the acquisition method of accounting. |
| ($ in thousands) |
Amount | |||
| Pro forma transaction accounting adjustments: |
||||
| Elimination of Nu Aires historical net book value of property, plant & equipment |
$ | (2,514 | ) | |
| Preliminary fair value of acquired property, plant & equipment |
7,095 | |||
|
|
|
|||
| Net pro forma transaction accounting adjustments to property, plant & equipment |
$ | 4,581 | ||
|
|
|
|||
| (d) | Preliminary goodwill adjustment of $13.0 million which represents the excess of the estimated purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. |
| (e) | Reflects the preliminary purchase accounting adjustment for estimated intangibles of $18.6 million based on the acquisition method of accounting. Refer to Note 3 above for additional information on the acquired intangible assets expected to be recognized. |
| (f) | Reflects the preliminary purchase accounting adjustment to right-of-use assets of $1.2 million, to measure the operating lease right-of-use assets at the same amount as the associated lease liability in accordance with the acquisition method of accounting, and also reflects the net favorable terms of the leases when compared with market terms. The calculated value is preliminary and subject to change and could vary materially from the final purchase price allocation. |
| (g) | Represents the adjustment to deferred tax assets of $5.3 million associated with the incremental differences in the book and tax basis created from the preliminary purchase allocation, primarily resulting from the preliminary fair value of intangible assets. These adjustments were based on the applicable statutory tax rate with the respective estimated purchase price allocation. The effective tax rate of the combined company could be significantly different (either higher or lower) depending on post-acquisition activities, including cash needs, the geographical mix of income and changes in tax law. Because the tax rates used for the pro forma financial information are estimated, the blended rate will likely vary from the actual effective rate in periods subsequent to completion of the Acquisition. This determination is preliminary and subject to change based upon the final determination of the fair value of the acquired assets and assumed liabilities. |
| (h) | Reflects the Revolving Credit Facility, Term Loan, and the Seller Notes to fund a portion of the Acquisition. The adjustment to current and long-term debt is comprised of the following items: |
| ($ in thousands) |
Current portion of financing liability |
Long-term portion of financing liability |
Total | |||||||||
| Pro forma transaction accounting adjustmentsfinancing: |
||||||||||||
| Revolving Credit Facility (i) |
$ | | $ | 5,563 | $ | 5,563 | ||||||
| Term Loan |
3,000 | 12,000 | 15,000 | |||||||||
| Seller Notes |
| 22,540 | 22,540 | |||||||||
|
|
|
|
|
|
|
|||||||
| Net pro forma transaction accounting adjustments -financing to current portion of long-term debt and long-term debt |
$ | 3,000 | $ | 40,103 | $ | 43,103 | ||||||
|
|
|
|
|
|
|
|||||||
| i) | $0.1 million of fees related to the establishment of the $20.0 million senior secured revolving credit facility pursuant to the Loan Agreement is capitalized to other assets. |
| (i) | Represents additional transaction costs to be incurred by Kewaunee subsequent to October 31, 2024. These costs are not expected to affect Kewaunees condensed combined statement of operations beyond twelve months after the acquisition date. |
| (j) | Reflects the adjustments to Stockholders equity: |
| ($ in thousands) |
Common Stock | Additional Paid-in Capital | Retained Earnings | |||||||||
| Pro forma transaction accounting adjustments: |
||||||||||||
| Elimination of Nu Aires historical equity |
$ | (30 | ) | $ | (12 | ) | $ | (19,186 | ) | |||
| Estimated transaction costs (i) |
| | (698 | ) | ||||||||
|
|
|
|
|
|
|
|||||||
| Net pro forma transaction accounting adjustments to equity |
$ | (30 | ) | $ | (12 | ) | $ | (19,884 | ) | |||
|
|
|
|
|
|
|
|||||||
| i) | These costs consist of financial advisory, legal advisory, accounting and consulting costs. |
Note 5 Pro Forma Adjustments to the Unaudited Condensed Combined Statement of Operations
Adjustments included in the Transaction Accounting Adjustments column and Transaction Accounting Adjustments Financing column in the accompanying unaudited pro forma condensed combined statement of operations for the six months ended October 31, 2024 and fiscal year ended April 30, 2024 are as follows:
(a) Reflects the adjustments to cost of products sold. This includes $636,000 for the fiscal year ended April 30, 2024, relating to the estimated fair value of inventories recognized through cost of products sold during the first year after the Acquisition and $8,696 and $2,011 for the six months ended October 31, 2024 and fiscal year ended April 30, 2024, respectively, relating to the incremental depreciation expense from the fair value adjustment to property, plant and equipment.
(b) Reflects the adjustments to operating expenses including the amortization of the estimated fair value of intangibles, the incremental depreciation expense from the fair value adjustment to property, plant, and equipment, and the estimated transaction costs expensed.
| ($ in thousands) |
For the Six Months Ended October 31, 2024 |
For the Year Ended April 30, 2024 |
||||||
| Pro forma transaction accounting adjustments: |
||||||||
| Amortization of intangible assets |
$ | 882 | $ | 1,764 | ||||
| Property, plant and equipment depreciation step-up |
23 | 5 | ||||||
| Expected transaction expenses (i) |
| 698 | ||||||
|
|
|
|
|
|||||
| Net pro forma transaction accounting adjustment to operating expenses |
$ | 905 | $ | 2,467 | ||||
|
|
|
|
|
|||||
| i) | Represents additional transaction costs to be incurred by Kewaunee subsequent to October 31, 2024. These costs are not expected to affect Kewaunees condensed combined statement of operations beyond twelve months after the acquisition date. |
(c) Reflects the expense related to the financing and amortization of issuance costs related to the Acquisition:
| ($ in thousands) |
For the Six Months Ended October 31, 2024 |
For the Year Ended April 30, 2024 |
||||||
| Pro forma transaction accounting adjustmentsfinancing: |
||||||||
| Revolving Credit Facility |
$ | (266 | ) | $ | (512 | ) | ||
| Term Loan |
(378 | ) | (905 | ) | ||||
| Seller Notes |
(1,090 | ) | (2,062 | ) | ||||
|
|
|
|
|
|||||
| Net pro forma transaction accounting adjustmentsfinancing to interest expense |
$ | (1,734 | ) | $ | (3,479 | ) | ||
|
|
|
|
|
|||||
The new interest expense on transaction financing adjustments included in the unaudited pro forma condensed combined statement of operations reflect the interest expense associated with new debt from the commitment parties. Interest was recognized for the Revolving Credit Facility, Term Loan, and the Seller Notes using the effective interest method with the rate equal to the Adjusted Secured Overnight Financing Rate (SOFR) plus 1.6% per annum for the Revolving Facility and Term Loan, and 8.0% for the Seller Notes. The costs incurred to secure the Revolving Credit Facility of $5,250 and $10,500 for the six months ended October 31, 2024 and fiscal year ended April 30, 2024, respectively, are amortized to operating expenses on a straight-line basis over the five year term of the commitment.
A sensitivity analysis on interest expense has been performed to assess the effect of a 12.5 basis point change of the hypothetical interest on the debt financing. This change would cause a corresponding increase or decrease in the interest expense of approximately $28,900 for the six months ending October 31, 2024 and $55,969 for the year ended April 30, 2024.
(d) To record the income tax impact of the pro forma adjustments utilizing a statutory income tax rate in effect of 21% for the year ended April 30, 2024 and for the six months ended October 31, 2024. The effective tax rate of the combined company could be significantly different (either higher or lower) depending on post-Acquisition activities, including cash needs, the geographical mix of income and changes in tax law. Because the tax rates used for the pro forma financial information are estimated, the blended rate will likely vary from the actual effective rate in periods subsequent to completion of the Acquisition. This determination is preliminary and subject to change based upon the final determination of the fair value of the acquired assets and assumed liabilities.
(e) In connection with the Acquisition, no additional shares were issued. Accordingly, the pro forma basic and diluted weighted average shares outstanding are as follows:
| ($ and shares in thousands, except per share amounts) |
For the Six Months Ended October 31, 2024 |
For the Year Ended April 30, 2024 |
||||||
| Pro forma net earnings per share: |
||||||||
| Pro forma net earnings attributable to Kewaunee Scientific Corporation stockholders |
$ | 4,873 | $ | 18,579 | ||||
| Weighted average shares outstanding - basic |
2,861 | 2,879 | ||||||
| Weighted average shares outstanding - diluted |
2,971 | 2,938 | ||||||
| Pro forma earnings per share attributable to common stockholders - basic |
$ | 1.70 | $ | 6.45 | ||||
|
|
|
|
|
|||||
| Pro forma earnings per share attributable to common stockholders - diluted |
$ | 1.64 | $ | 6.32 | ||||
|
|
|
|
|
|||||